POLYMORPHISM IN THE PROMOTER REGION OF THE APOLIPOPROTEIN AI GENE ASSOCIATED WITH DIFFERENCES IN APOLIPOPROTEIN AI LEVELS - THE EUROPEAN ATHEROSCLEROSIS RESEARCH STUDY

被引:64
作者
TALMUD, PJ
YE, S
HUMPHRIES, SE
机构
[1] Division of Cardiovascular Genetics, Department of Medicine, Rayne Institute, University College London Medical School, London
关键词
APO AI; HDL; ENVIRONMENTAL FACTORS; GENETIC VARIATION; EARS;
D O I
10.1002/gepi.1370110305
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The effect associated with the substitution of adenine (A) for guanidine (G) in the promoter region of the apolipoprotein Al gene (-75 bp) with plasma apo AI and high-density lipoprotein (HDL) levels was investigated in the European Atherosclerosis Research Study (EARS). This is a study of healthy offspring (cases) of fathers who had suffered premature myocardial infarction (MI) before age 55 years (n = 565) and age- and sex-matched controls (n = 1,078) from 12 European countries, divided into 5 regions based on geography and language. The frequency of the polymorphism was not significantly different among the regions and the relative frequency of the rare A allele was similar in cases and controls (0.159 vs. 0.142) combining data from all regions. Individuals with one or more A allele had significantly higher plasma apo AI levels (P < 0.05) than individuals homozygous for the G allele. This effect was consistent in all regions. The data were analyzed separately in males and females. In females, those with one or more A allele had significantly higher apo AI levels (P = 0.05) than individuals homozygous for the G allele, and this raising effect of the A allele was greater in cases than controls for both apo AI (5.23% vs. 1.56%) and HDL (4.48% vs. 1.89%). In males, the A allele was associated with higher levels of apo AI and HDL, but the effect was much smaller and the differences did not reach statistical significance. In the females, where the effect of the A allele was strongest, the effect on apo Al associated with genotype was evident in non-smokers, and individuals with one or two A alleles had 3.6% higher apo AI and 3.14% higher HDL levels than individuals homozygous for the G allele. However, in the female smokers the raising effect of the A allele was greatly reduced (0.56%). Thus genetic variation in the promoter region of the apo Al gene is associated with differences in apo Al and HDL levels in healthy individuals throughout Europe, but the effect is modulated by gender, environmental factors such as smoking, and a family history of MI. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:265 / 280
页数:16
相关论文
共 40 条
[31]  
ROSSENEU M, 1994, IN PRESS CIRCULATION
[32]   INTERACTION BETWEEN A POLYMORPHISM OF THE APO A-I PROMOTER REGION AND SMOKING DETERMINES PLASMA-LEVELS OF HDL AND APO A-I [J].
SIGURDSSON, G ;
GUDNASON, V ;
SIGURDSSON, G ;
HUMPHRIES, SE .
ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (09) :1017-1022
[33]   POLYMORPHISM IN THE HUMAN APOLIPOPROTEIN-A-I GENE PROMOTER REGION - ASSOCIATION OF THE MINOR ALLELE WITH DECREASED PRODUCTION-RATE INVIVO AND PROMOTER ACTIVITY INVITRO [J].
SMITH, JD ;
BRINTON, EA ;
BRESLOW, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (06) :1796-1800
[34]   A PROSPECTIVE-STUDY OF CHOLESTEROL, APOLIPOPROTEINS, AND THE RISK OF MYOCARDIAL-INFARCTION [J].
STAMPFER, MJ ;
SACKS, FM ;
SALVINI, S ;
WILLETT, WC ;
HENNEKENS, CH .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (06) :373-381
[35]  
TENKANEN H, 1991, HUM GENET, V87, P574
[36]   TRANSCRIPTION EFFICIENCY OF HUMAN APOLIPOPROTEIN-A-I PROMOTER VARIES WITH NATURALLY-OCCURRING A-TO-G TRANSITION [J].
TUTEJA, R ;
TUTEJA, N ;
MELO, C ;
CASARI, G ;
BARALLE, FE .
FEBS LETTERS, 1992, 304 (01) :98-101
[37]   APOLIPOPROTEIN-A-I GENE POLYMORPHISMS - FREQUENCY IN PATIENTS WITH CORONARY-ARTERY DISEASE AND HEALTHY CONTROLS AND ASSOCIATION WITH SERUM APO-A-I AND HDL-CHOLESTEROL CONCENTRATION [J].
WILE, DB ;
BARBIR, M ;
GALLAGHER, J ;
MYANT, NB ;
RITCHIE, CD ;
THOMPSON, GR ;
HUMPHRIES, SE .
ATHEROSCLEROSIS, 1989, 78 (01) :9-18
[38]   ROLE OF GENETIC-VARIATION AT THE APO AI-CIII-AIV GENE-CLUSTER IN DETERMINING PLASMA APO AI LEVELS IN BOYS AND GIRLS [J].
XU, CF ;
ANGELICO, F ;
DELBEN, M ;
HUMPHRIES, S .
GENETIC EPIDEMIOLOGY, 1993, 10 (02) :113-122
[39]  
ZANNIS VI, 1992, CURR OPIN LIPIDOL, V3, P96
[40]  
1994, IN PRESS INT J EPIDE